Ultraviolet Blood Irradiation

Ultraviolet blood irradiation is an important part of our comprehensive cancer care program.

UBI therapy is, in effect the electronic application of UV energy to about 5 percent of the patient’s blood. On its return to the vein, the small quantity of irradiated blood exerts an action on the total blood in accordance with the laws of spectral energy.

The first treatment of a human with UBI occurred in 1928, the successful healing of a woman patient who was apparently moribund from septic abortion, complicated by hemolytic streptococcus septicemia. She subsequently bore two children.

Ultraviolet blood irradiation was initially developed by the research findings of E.K. Knott. He was looking for a way to combat the effects of poliomyelitis during the 1930’s. He accomplished considerable success with this treatment.

The introduction of the Salk vaccines and antibiotics in the 1950’s and 1960’s dramatically slowed the use of UBI. What followed was quite a time gap of doctors who omitted this treatment from their practice. UBI was re-introduced in the 1980’s and has continued to grow in use by alternative practitioners throughout the US.

Among the more important physiological fundamentals that UBI has been found to provide are bactericidal properties, detoxification effect, vasodilation, photosensitization and photodynamic effects, effects on various proteins, the ability of plasma treated to absorb oxygen, secondary emanatory phenomena, and effect of general resistance.

Ultraviolet blood irradiation, how does this treatment work?